Development and Validation of an In Vitro Resazurin-Based Susceptibility Assay against Madurella mycetomatis
Open Access
- 17 February 2021
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 65 (3)
Abstract
We present an in vitro susceptibility assay for Madurella mycetomatis hyphae using resazurin for endpoint reading. Using this assay, reproducible MICs were obtained for amphotericin B, itraconazole, voriconazole, posaconazole, terbinafine, and micafungin.Keywords
This publication has 14 references indexed in Scilit:
- Mycetoma epidemiology, diagnosis management, and outcome in three hospital centres in Senegal from 2008 to 2018PLOS ONE, 2020
- Pyomelanin Secretion in Madurella mycetomatis Interferes with Spectrophotometric Endpoint Reading Using the Sensititre YeastOne alamarBlue Assay but Not with Visual Endpoint ReadingAntimicrobial Agents and Chemotherapy, 2019
- Mycetoma: a unique neglected tropical diseaseThe Lancet Infectious Diseases, 2016
- Madurella mycetomatis Is Highly Susceptible to RavuconazolePLOS Neglected Tropical Diseases, 2014
- Antifungal Drug Discovery: The Process and OutcomesFuture Microbiology, 2014
- In Vitro Susceptibility of Madurella mycetomatis to Posaconazole and TerbinafineAntimicrobial Agents and Chemotherapy, 2011
- Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal AgentsAntimicrobial Agents and Chemotherapy, 2010
- In Vitro Susceptibilities of Madurella mycetomatis to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2 H - Tetrazolium Hydroxide (XTT) AssayAntimicrobial Agents and Chemotherapy, 2004
- Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicityEuropean Journal of Biochemistry, 2000
- Treatment of eumycetoma and actinomycetoma.1995